{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:11:11Z","timestamp":1778814671424,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,2]],"date-time":"2027-05-02T00:00:00Z","timestamp":1809216000000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.pan.2026.03.007","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:30:54Z","timestamp":1773361854000},"page":"459-468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancreatic cancer"],"prefix":"10.1016","volume":"26","author":[{"given":"Naohiro","family":"Hirano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koetsu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4221-0236","authenticated-orcid":false,"given":"Shuichi","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8823-6696","authenticated-orcid":false,"given":"Shingo","family":"Yoshimachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9688-4956","authenticated-orcid":false,"given":"Hideaki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4147-8081","authenticated-orcid":false,"given":"Mitsuhiro","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Iseki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4582-6589","authenticated-orcid":false,"given":"Daisuke","family":"Douchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keigo","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimpei","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9744-5537","authenticated-orcid":false,"given":"Takayuki","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6436-5477","authenticated-orcid":false,"given":"Masamichi","family":"Mizuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Masamune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Unno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2026.03.007_bib1","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.pan.2026.03.007_bib2","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3390\/diagnostics11030562","article-title":"Pancreatic ductal adenocarcinoma: epidemiology and risk factors","volume":"11","author":"Ushio","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.pan.2026.03.007_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41568-021-00418-1","article-title":"Pancreatic cancer evolution and heterogeneity: integrating omics and clinical data","volume":"22","author":"Connor","year":"2022","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pan.2026.03.007_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5582\/bst.2021.01103","article-title":"Trends in the treatment of pancreatic cancer in Japan","volume":"15","author":"Matsuki","year":"2021","journal-title":"BioSci Trends"},{"key":"10.1016\/j.pan.2026.03.007_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-76025-1","article-title":"Prediction of survival and recurrence in patients with pancreatic cancer by integrating multi-omics data","volume":"10","author":"Baek","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.pan.2026.03.007_bib6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/cas.12501","article-title":"Phase II study of FOLFIRINOX for chemotherapy-na\u00efve Japanese patients with metastatic pancreatic cancer","volume":"105","author":"Okusaka","year":"2014","journal-title":"Cancer Sci"},{"key":"10.1016\/j.pan.2026.03.007_bib7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00280-016-2972-3","article-title":"Phase I\/II study of nab-paclitaxel plus gemcitabine for chemotherapy-naive Japanese patients with metastatic pancreatic cancer","volume":"77","author":"Ueno","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.pan.2026.03.007_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","article-title":"Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance","volume":"18","author":"Sherman","year":"2023","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"10.1016\/j.pan.2026.03.007_bib9","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic targeting of the tumor microenvironment","volume":"11","author":"Bejarano","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.pan.2026.03.007_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-3-030-36214-0_2","article-title":"Gastric tumor microenvironment","volume":"1226","author":"Rojas","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.pan.2026.03.007_bib11","doi-asserted-by":"crossref","first-page":"6206","DOI":"10.3390\/cancers13246206","article-title":"The colorectal cancer tumor microenvironment and its impact on liver and lung metastasis","volume":"13","author":"Chandra","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pan.2026.03.007_bib12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2022.01.015","article-title":"Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer","volume":"530","author":"Kang","year":"2022","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pan.2026.03.007_bib13","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.3390\/cancers13164233","article-title":"Tumor microenvironment in breast cancer-updates on therapeutic implications and pathologic assessment","volume":"13","author":"Li","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.pan.2026.03.007_bib14","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.pan.2026.03.007_bib15","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","article-title":"Cancer-associated fibroblasts: from basic science to anticancer therapy","volume":"55","author":"Yang","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.pan.2026.03.007_bib16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0006-291X(03)01544-4","article-title":"Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction","volume":"309","author":"Ishii","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pan.2026.03.007_bib17","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1158\/0008-5472.CAN-07-2477","article-title":"Pancreatic stellate cells: partners in crime with pancreatic cancer cells","volume":"68","author":"Vonlaufen","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.pan.2026.03.007_bib18","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/gut.44.4.534","article-title":"Pancreatic stellate cells are activated by proinflammatory cytokines: implications for pancreatic fibrogenesis","volume":"44","author":"Apte","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.pan.2026.03.007_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413408","article-title":"Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma: an update on heterogeneity and therapeutic targeting","volume":"22","author":"Vaish","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pan.2026.03.007_bib20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1186\/s13046-022-02519-7","article-title":"Patient-specific modeling of stroma-mediated chemoresistance of pancreatic cancer using a three-dimensional organoid-fibroblast co-culture system","volume":"41","author":"Schuth","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.pan.2026.03.007_bib21","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1200\/JCO.2015.62.8719","article-title":"Randomized phase Ib\/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer","volume":"33","author":"Catenacci","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.pan.2026.03.007_bib22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.pan.2026.03.007_bib23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-induced JAK\/STAT signaling is antagonized by TGF\u03b2 to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.pan.2026.03.007_bib24","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1128\/MCB.21.15.5132-5141.2001","article-title":"Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway","volume":"21","author":"Furuhashi","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.pan.2026.03.007_bib25","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","article-title":"TGF-beta signal transduction","volume":"67","author":"Massagu\u00e9","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.pan.2026.03.007_bib26","article-title":"Smad3 promotes cancer-associated fibroblasts generation via macrophage-myofibroblast transition","volume":"9","author":"Tang","year":"2022","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.pan.2026.03.007_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/CS20120252","article-title":"Role of the TGF-\u03b2\/BMP-7\/Smad pathways in renal diseases","volume":"124","author":"Meng","year":"2013","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.pan.2026.03.007_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/rheumatology\/kei124","article-title":"Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts","volume":"45","author":"Ihn","year":"2006","journal-title":"Rheumatol (Oxf Engl)"},{"key":"10.1016\/j.pan.2026.03.007_bib29","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1002\/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#","article-title":"CRTH2 is the most reliable marker for the detection of circulating human type 2 th and type 2 T cytotoxic cells in health and disease","volume":"30","author":"Cosmi","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.pan.2026.03.007_bib30","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020107403","article-title":"ER-anchored CRTH2 antagonizes collagen biosynthesis and organ fibrosis via binding LARP6","volume":"40","author":"Zuo","year":"2021","journal-title":"EMBO J"},{"key":"10.1016\/j.pan.2026.03.007_bib31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1165\/rcmb.2021-0504OC","article-title":"CRTH2 mediates profibrotic macrophage differentiation and promotes lung fibrosis","volume":"67","author":"Cao","year":"2022","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pan.2026.03.007_bib32","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1681\/ASN.2012020126","article-title":"PGD2-CRTH2 pathway promotes tubulointerstitial fibrosis","volume":"23","author":"Ito","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pan.2026.03.007_bib33","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.17305\/bb.2024.10485","article-title":"Advances in PGD2\/PTGDR2 signaling pathway in tumors: a review","volume":"24","author":"Tian","year":"2024","journal-title":"Biomol Biomed"},{"key":"10.1016\/j.pan.2026.03.007_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1385\/IJGC:32:1:7","article-title":"Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells","volume":"32","author":"Hashimoto","year":"2002","journal-title":"Int J Gastrointest Cancer"},{"key":"10.1016\/j.pan.2026.03.007_bib35","doi-asserted-by":"crossref","first-page":"38502","DOI":"10.1074\/jbc.M107081200","article-title":"Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3","volume":"276","author":"Yuan","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pan.2026.03.007_bib36","doi-asserted-by":"crossref","first-page":"12838","DOI":"10.1096\/fj.201802608R","article-title":"Crth2 receptor signaling down-regulates lipopolysaccharide-induced NF-\u03baB activation in murine macrophages via changes in intracellular calcium","volume":"33","author":"Diwakar","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.pan.2026.03.007_bib37","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201460","article-title":"STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer","volume":"5","author":"Lefler","year":"2022","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.pan.2026.03.007_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cac2.12392","article-title":"Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives","volume":"43","author":"Fang","year":"2023","journal-title":"Cancer Commun"},{"key":"10.1016\/j.pan.2026.03.007_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.canlet.2020.03.004","article-title":"Extracellular vesicle packaged LMP1-activated fibroblasts promote tumor progression via autophagy and stroma-tumor metabolism coupling","volume":"478","author":"Wu","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pan.2026.03.007_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14677","article-title":"Smad3 promotes cancer progression by inhibiting E4BP4-mediated NK cell development","volume":"8","author":"Tang","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.pan.2026.03.007_bib41","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/labinvest.2014.53","article-title":"Upregulated SMAD3 promotes epithelial-mesenchymal transition and predicts poor prognosis in pancreatic ductal adenocarcinoma","volume":"94","author":"Yamazaki","year":"2014","journal-title":"Lab Invest"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390326001274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390326001274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:33:09Z","timestamp":1778812389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390326001274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1424390326001274"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2026.03.007","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SMAD3 activation in pancreatic stellate cells correlates with PTGDR2 expression and favorable stromal features in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2026.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 IAP and EPC. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}